HAMILTON THORNE LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.37 CAD | +0.74% |
|
+1.48% | +3.01% |
| Sales 2024 * | 79.27M 108M | Sales 2025 * | 86.74M 119M | Capitalization | 153M 209M |
|---|---|---|---|---|---|
| Net income 2024 * | 4M 5.47M | Net income 2025 * | 6M 8.2M | EV / Sales 2024 * | 1.99 x |
| Net Debt 2024 * | 4.9M 6.7M | Net cash position 2025 * | 5.2M 7.11M | EV / Sales 2025 * | 1.7 x |
| P/E ratio 2024 * |
33.4
x | P/E ratio 2025 * |
25
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.11% |
More Fundamentals
* Assessed data
More news
Latest transcript on Hamilton Thorne Ltd.
More press releases
| 1 day | +0.74% | ||
| 1 week | +1.48% | ||
| Current month | +5.38% | ||
| 1 month | +5.38% | ||
| 3 months | +5.38% | ||
| 6 months | -2.14% | ||
| Current year | +3.01% |
1 week
1.33
1.37
1 month
1.291.41
Current year
1.251.49
1 year
1.051.70
3 years
1.052.20
5 years
0.862.20
10 years
0.052.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | Jan. 14 | |
David Wolf
CHM | Chairman | - | 11-08-31 |
| Director of Finance/CFO | - | 22-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Thorne
BRD | Director/Board Member | - | 09-10-27 |
| Chief Executive Officer | - | Jan. 14 | |
Kari Firestone
BRD | Director/Board Member | - | 22-01-17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 1.37 | +0.74% | 36,200 |
| 24-04-25 | 1.36 | 0.00% | 21,300 |
| 24-04-24 | 1.36 | 0.00% | 20,940 |
| 24-04-23 | 1.36 | +0.74% | 41,790 |
| 24-04-22 | 1.35 | 0.00% | 20,602 |
End-of-day quote Toronto S.E., April 25, 2024
More quotes
Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.
Calendar
2024-05-21
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.001
USD
Average target price
1.665
USD
Spread / Average Target
+66.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.01% | 153M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- HTL Stock
